搜尋結果
In June 2023, the FDA advised manufacturers that the 2023–2024 formulation of the COVID-19 vaccines for use in the US be updated to be a monovalent COVID-19 vaccine using the XBB.1.5 lineage of the Omicron variant.
The COVID-19 pandemic, also known as the coronavirus pandemic, is a global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in an outbreak in Wuhan, the capital of Hubei, China, in December 2019, before it spread to other areas of Asia, and then worldwide in early 2020.
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019.[7] The disease quickly spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 are variable but often include fever,[8] fatigue, cough, breathing ...
XBB, a recombinant of the BA.2.10.1.1 and BA.2.75.3.1.1.1 sublineages, is an Omicron subvariant first detected in August 2022. [178] On 20 October 2022, the chief scientist of the World Health Organization (WHO), Soumya Swaminathan, warned that the XBB subvariant of Omicron may cause infections in some countries while the severity of ...
Vaxart. Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery ...
CRISPR (/ ˈ k r ɪ s p ər /) (an acronym for clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. ...
The Airbus A350 is a long-range, wide-body twin-engine airliner developed and produced by Airbus. The initial A350 design proposed by Airbus in 2004, in response to the Boeing 787 Dreamliner, would have been a development of the Airbus A330 with composite wings and new engines. Due to inadequate market support, Airbus switched in 2006 to a ...
